TYNDALL CAPITAL PARTNERS L P sold 15.1% of their position (112.36K shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $167.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/24/2019ACC: 0000905718-19-000785
10% Owner
Since Jun 2019
-112.36K
Net shares
Net seller
$167.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
112.36K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−75.12K
Price / share
$1.62
Trade value
$121.43K
% of position
10.1%
9/20/2019
745.45K→670.33K
Common Stock
Indirect
Shares
−37.24K
Price / share
$1.23
Trade value
$45.97K
% of position
5.6%
9/23/2019
670.33K→633.09K
Total
Net shares
−112.36K
Net value
-$167.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/20/2019 | S · Sale | −75.12K | $1.62 | $121.43K | 10.1% | 745.45K | 670.33K |
| Common Stock Indirect | 9/23/2019 | S · Sale | −37.24K | $1.23 | $45.97K | 5.6% | 670.33K | 633.09K |
| Total | −112.36K | -$167.40K | ||||||
Derivative Transactions0
No derivative transactions reported